Pfizer said a combination of two of its prostate cancer drugs — Talzenna and Xtandi — succeeded in a Phase 3 study and that it

Eli Lilly has positive phase 3 results for its triple agonist retatrutide in diabetes to go with its earlier encouraging data in obesity.

Washington’s Medicaid program will start paying for a friendly AI-powered robot called ElliQ to keep seniors company and help them stay independent and healthy at

GSK’s recent deal to license out a rare liver disease drug just got sweeter. The FDA on Thursday approved linerixibat to treat cholestatic itch in

As geopolitical tensions ratchet up around the world, an initiative has been launched to drive improvements in diagnostic accuracy and precision care.